Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer
Authors
Keywords
Cytotoxic T cells, T cells, Nutrition, Inflammation, Non-small cell lung cancer, Inflammatory diseases, Lung and intrathoracic tumors, Chronic obstructive pulmonary disease
Journal
PLoS One
Volume 9, Issue 9, Pages e106914
Publisher
Public Library of Science (PLoS)
Online
2014-09-20
DOI
10.1371/journal.pone.0106914
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation Status
- (2014) Audrey Mansuet-Lupo et al. CHEST
- Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
- (2013) Syed H Jafri et al. BMC CANCER
- Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
- (2013) J. Goc et al. CANCER RESEARCH
- Circulating Inflammation Markers and Prospective Risk for Lung Cancer
- (2013) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- Low Perioperative Serum Prealbumin Predicts Early Recurrence after Curative Pulmonary Resection for Non-Small-Cell Lung Cancer
- (2012) Hideki Kawai et al. WORLD JOURNAL OF SURGERY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer
- (2011) Marco Alifano et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Non-small-cell lung cancer
- (2011) Peter Goldstraw et al. LANCET
- Cancer and Inflammation: Implications for Pharmacology and Therapeutics
- (2010) F Balkwill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends
- (2010) Danny R. Youlden et al. Journal of Thoracic Oncology
- Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer
- (2010) Ana Belén Custodio et al. Journal of Thoracic Oncology
- Chemokines and chemokine receptors: new insights into cancer-related inflammation
- (2010) Gwendal Lazennec et al. TRENDS IN MOLECULAR MEDICINE
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Individualizing Chemotherapy for Non-small Cell Lung Cancer (NSCLC) in the Adjuvant and Advanced Setting: Current Status and Future Directions
- (2009) George R. Simon CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Systemic manifestations and comorbidities of COPD
- (2009) P. J. Barnes et al. EUROPEAN RESPIRATORY JOURNAL
- Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
- (2009) Kristine H. Allin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of C-Reactive Protein and Smoking in Patients with Advanced Non-small Cell Lung Cancer Treated with First-Line Palliative Chemotherapy
- (2009) Andrea Koch et al. Journal of Thoracic Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started